Difficulty: Medium
Average Score: 75%
Practice
Indicate D2 receptor agonist with antiparkinsonian activity:
Correct answer
C
Rationale
Rationale:
1. Bromocriptine is a D2 receptor agonist.
2. Stimulation of D2 receptors helps alleviate Parkinson's symptoms.
3. Sinemet and Levodopa are dopamine precursors but not D2 agonists.
4. Selegiline is a monoamine oxidase inhibitor, not a D2 agonist.
In summary, Bromocriptine directly activates D2 receptors, making it the correct choice for antiparkinsonian activity.
1. Bromocriptine is a D2 receptor agonist.
2. Stimulation of D2 receptors helps alleviate Parkinson's symptoms.
3. Sinemet and Levodopa are dopamine precursors but not D2 agonists.
4. Selegiline is a monoamine oxidase inhibitor, not a D2 agonist.
In summary, Bromocriptine directly activates D2 receptors, making it the correct choice for antiparkinsonian activity.